7 JCI-accredited hospitals 17 hospitals with oncology 65 oncology specialists 19 clinical trials recruiting
Oncology & Cancer Care
Prof. Hüsnü Görgen, MD
Gynecologic Oncology

Prof. Hüsnü Görgen, MD

Prof. Hüsnü Görgen, MD is a gynecology & obstetrics specialist at Acibadem Fulya Hospital. He has more than 41 years of experience in medicine and focuses on menopause care, hpv-related conditions, bladder health and…

  • Experience41+ years
  • HospitalFulya Hospital
  • LanguagesTurkish, English
  • FocusMenopoz, Ürojinekoloji, Urogynecology

About

Prof. Hüsnü Görgen, MD is a Gynecology and Obstetrics specialist at Acibadem Fulya Hospital. His clinical interests include urogynecology, menopause, endometriosis, pelvic pain and dysfunction, urinary incontinence, infertility, hysterectomy, HPV-related conditions, pelvic organ prolapse, and gynecological cancers.

He graduated from Istanbul University Istanbul Faculty of Medicine in 1985 and completed his Gynecology and Obstetrics training at Zeynep Kamil Women’s and Children’s Diseases Training and Research Hospital in 1993. He received specialization in Gynecological Oncology Surgery in 2011 and became a professor at Acibadem University Faculty of Medicine in 2015. His career has included clinical and leadership roles at Zeynep Kamil, Haydarpaşa Numune, Haseki Training and Research Hospital, and Acibadem Healthcare Services.

International patients can expect consultation focused on their gynecological concerns, with attention to symptoms, diagnosis, and available treatment approaches. Prof. Görgen’s areas of practice include benign gynecological conditions, pelvic floor and bladder health, reproductive concerns, and gynecological oncology.

Expertise

Conditions treated

  • Menopause care
  • Hpv-related conditions
  • Bladder health and urinary incontinence
  • Infertility
  • Cervical cancer
  • Uterine prolapse
  • Ovarian cancer

Procedures and treatments

  • Endometriosis treatment
  • Pelvic organ prolapse treatment
  • Hysterectomy
  • Urinary incontinence treatment
  • Infertility treatment
  • Cervical cancer treatment
  • Ovarian cancer treatment

Education and career

Timeline

  1. 2015Acıbadem University Faculty of Medicine / ProfessorEducation
  2. 2011Medical Specialization Board Gynecologic Oncology SurgeryEducation
  3. 2006Acıbadem Healthcare ServicesCareer
  4. 2002–2010Haseki Training and Research Hospital / Deputy Clinical ChiefCareer
  5. 2000–2002Haydarpaşa Numune Training and Research Hospital / Obstetrics and Gynecology Clinic, Deputy ChiefCareer
  6. 1997–1999Private Haznedar Hospital / Obstetrics and Gynecology SpecialistCareer
  7. 1996–1997Zeynep Kamil Women's and Children's Diseases Training and Research Hospital / Deputy Chief PhysicianCareer
  8. 1993Zeynep Kamil Women's and Children's Diseases Training and Research Hospital Obstetrics and GynecologyEducation
  9. 1993–1997Zeynep Kamil Women's and Children's Diseases Training and Research Hospital / Chief Assistant DoctorCareer
  10. 1989–1993Zeynep Kamil Women's and Children's Diseases Training and Research Hospital / Assistant DoctorCareer
  11. 1987–1989108th Artillery Regiment / Medical Second LieutenantCareer
  12. 1985İstanbul University İstanbul Faculty of MedicineEducation
  13. 1985–1987Anıtkaya Health Center Physician / General PractitionerCareer

Memberships

  • Turkish Gynecology Association
  • Gynecologic Oncology Association
  • The European Society of Gynecological Oncology
  • American Association of Gynecologic Laparoscopists
  • The American Society for Colposcopy and Cervical Pathology

Tumour boards

Cancer types where Prof. Hüsnü Görgen, MD is part of the specialist team

This page is general information from Acıbadem oncology teams and does not replace a consultation. Treatment decisions are made after a review of your reports by a tumour board.

Second opinion · Free case review

Send your reports and get a plan from a tumour board, not a single doctor

Pathology, imaging and previous treatment history are enough to start. Written recommendation within 48 hours, including trial eligibility.